LIFECORE BIOMEDICAL, INC. Purchase Commitment, Remaining Minimum Amount Committed
LIFECORE BIOMEDICAL, INC. (LFCR) had Purchase Commitment, Remaining Minimum Amount Committed of $54.90 million as of 2021-05-30, per its 10-K/A filed 2023-03-16.
Discontinued › Notes › Commitment and Contingencies
us-gaap:PurchaseCommitmentRemainingMinimumAmountCommitted · last filed 2023-03-16
- 2021-05-30: Purchase Commitment, Remaining Minimum Amount Committed $54.90M; Purchase Commitment, Remaining Minimum Amount Committed as first filed $75.40M.
- 2020-05-31: Purchase Commitment, Remaining Minimum Amount Committed $87.70M.
- 2019-05-26: Purchase Commitment, Remaining Minimum Amount Committed $30.60M.
- 2018-05-27: Purchase Commitment, Remaining Minimum Amount Committed $24.40M.
| Period end | Purchase Commitment, Remaining Minimum Amount Committed | Purchase Commitment, Remaining Minimum Amount Committed as first filed |
|---|---|---|
| 2021-05-30 | $54.90M 10-K/A · filed 2023-03-16 | $75.40M 10-K · filed 2021-07-29 |
| 2020-05-31 | $87.70M 10-K · filed 2020-08-14 | |
| 2019-05-26 | $30.60M 10-K · filed 2019-08-01 | |
| 2018-05-27 | $24.40M 10-K · filed 2018-08-09 | |
| 2017-05-28 | $19.10M 10-K/A · filed 2018-03-15 | |
| 2016-05-29 | $23.70M 10-K · filed 2016-08-01 | |
| 2015-05-31 | $15.10M 10-K · filed 2015-07-31 | |
| 2014-05-25 | $5.00M 10-K · filed 2014-08-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |